MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

107.03 -0.17 (-0.16%)
Delayed Quote Updated: 9:54 AM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
iRhythm (NASDAQ:IRTC) Beats Expectations in Strong Q3, Stock Soars
Medical technology company iRhythm Technologies (NASDAQ:IRTC) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 30.7% year on year to $192.9 million. The company’s full-year revenue... 
Via StockStory
News headline image
iRhythm Technologies Announces Third Quarter 2025 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
iRhythm Earnings: What To Look For From IRTC
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results this Thursday after market close. Here’s what you need to know. 
Via StockStory
News headline image
3 Unprofitable Stocks We Find Risky
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
How Is The Market Feeling About iRhythm Technologies? ↗
 
Via Benzinga
News headline image
Where iRhythm Technologies Stands With Analysts ↗
 
Via Benzinga
News headline image
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025
From iRhythm
Via GlobeNewswire
News headline image
Forecasting The Future: 14 Analyst Projections For iRhythm Technologies ↗
 
Via Benzinga
News headline image
Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
What's Driving the Market Sentiment Around iRhythm Technologies Inc? ↗
 
Via Benzinga
News headline image
Q2 Earnings Recap: iRhythm (NASDAQ:IRTC) Tops Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Healthcare Stocks to Research Further and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
News headline image
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics Government World Trade
News headline image
IRHYTHM TECHNOLOGIES INC (NASDAQ:IRTC) Combines Technical Strength and Growth Momentum ↗
IRTC stock combines strong technical trends with accelerating fundamentals, aligning with Mark Minervini's high-growth strategy for potential continued gains. 
Via Chartmill
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 We Question
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
Expert Outlook: iRhythm Technologies Through The Eyes Of 9 Analysts ↗
 
Via Benzinga
News headline image
1 Growth Stock to Add to Your Roster and 2 We Brush Off
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who... 
Via StockStory
News headline image
IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
3 Overrated Stocks with Open Questions
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
From iRhythm
Via GlobeNewswire
News headline image
3 Unprofitable Stocks We Steer Clear Of
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
iRhythm Technologies to Participate in Upcoming Investor Conferences
From iRhythm
Via GlobeNewswire
News headline image
This Figma Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday ↗
 
Via Benzinga
News headline image
Investor Short Report Flags Steep Downside Risk For iRhythm Technologies ↗
Spruce Point Capital warned iRhythm Technologies could face a 40%–70% stock decline, citing regulatory risks and product safety issues. 
Via Benzinga
News headline image
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority
From iRhythm
Via GlobeNewswire
News headline image
Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
News headline image
IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 26.1% year on year to $186.7 million. The company’s... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know
A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index... 
Via StockStory
Topics Bonds Economy Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story